- AMINO SPHINGOGLYCOLIPID ANALOGUES
-
The invention relates to amino sphingoglycolipid analogues and peptide derivatives thereof, compositions comprising these compounds and methods of treating or preventing diseases or conditions using such compounds, especially diseases or conditions relati
- -
-
Page/Page column 67-68
(2016/01/22)
-
- NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity
-
It is known that T cells can eliminate tumour cells through recognition of unique or aberrantly expressed antigens presented as peptide epitopes by major histocompatibility complex (MHC) molecules on the tumour cell surface. With recent advances in defini
- Anderson, Regan J.,Compton, Benjamin J.,Tang, Ching-Wen,Authier-Hall, Astrid,Hayman, Colin M.,Swinerd, Gene W.,Kowalczyk, Renata,Harris, Paul,Brimble, Margaret A.,Larsen, David S.,Gasser, Olivier,Weinkove, Robert,Hermans, Ian F.,Painter, Gavin F.
-
p. 5120 - 5127
(2015/08/24)
-
- ORGANIC COMPOUNDS
-
This invention relates to sphingoglycolipid analogues, compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer.
- -
-
-
- CONJUGATE COMPOUNDS
-
The invention relates to sphingoglycolipid analogues and peptide derivatives thereof, which are useful in treating or preventing diseases or such as those relating to infection, atopic disorders, autoimmune diseases or cancer.
- -
-
Page/Page column 73
(2014/06/24)
-